Get notified when LIPO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisted (new) — The company has received delisting notices and must meet conditions to remain listed.
Lipella Pharmaceuticals files to sell up to $2.6M of common stock in at-the-market offering
Filed April 4, 2025 · ~1 min read
Key Changes
-
high
Lipella Pharmaceuticals entered an at-the-market sales agreement with H.C. Wainwright to sell up to $2,641,881 of common stock.
The Offering verify on EDGAR → -
medium
The company will pay the sales agent a 3.0% commission on gross sales, reducing net proceeds.
The Offering verify on EDGAR → -
medium
Net proceeds are intended for working capital and general corporate purposes, with management retaining broad discretion.
Use of Proceeds verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
Partner
Trade LIPO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify